Rankings
▼
Calendar
NVCR Q1 2024 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena
NVCR
NovoCure Limited
$1B
Q1 2024 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$139M
+13.4% YoY
Gross Profit
$105M
75.7% margin
Operating Income
-$42M
-30.0% margin
Net Income
-$39M
-28.0% margin
EPS (Diluted)
$-0.36
QoQ Revenue Growth
+3.5%
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$43M
Stock-Based Comp.
$34M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$762M
Stockholders' Equity
$359M
Cash & Equivalents
$454M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$139M
$122M
+13.4%
Gross Profit
$105M
$93M
+13.2%
Operating Income
-$42M
-$60M
+31.1%
Net Income
-$39M
-$53M
+27.0%
Geographic Segments
UNITED STATES
$91M
56%
International Markets
$43M
27%
GERMANY
$16M
10%
JAPAN
$8M
5%
CHINA
$5M
3%
← FY 2024
All Quarters
Q2 2024 →